WHEN: Wednesday 15 April 2026

TIME: 7:30-9:00pm AEST

Early stage type 1 diabetes (T1D) is a critical yet poorly understood phase preceding clinical diagnosis. With 90% of diagnoses occurring without a family history, many individuals progress silently through islet autoimmunity until presenting with life-threatening diabetic ketoacidosis (DKA).

​This webinar provides a case-based approach to navigating the GP’s role in early identification and shared care. Using a single case study followed across key decision points, clinical experts will guide you through pre-test counselling, interpreting islet autoantibodies, and applying the international three-stage framework. You will learn to identify high-risk phenotypes, establish evidence-based monitoring cadences, and recognise urgent “red flags” for specialist referral. The session also explores emerging disease-modifying therapies and practical strategies to reduce diagnostic delay, equipping you to support families with clarity and confidence.

LEARNING OUTCOMES:

  • Apply a structured GP approach to early stage T1D across key clinical decision points to guide when to test, how to counsel, and when to refer.
  • Interpret autoantibody and baseline glycaemic results in context, recognising which findings require routine referral, urgent escalation, or ongoing shared care, and avoiding common management gaps after results are returned.
  • Support patients and families once specialist care is established, including communicating risk, managing uncertainty and anxiety, and responding appropriately to questions and concerns.

REGISTERE HERE